vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and New Fortress Energy Inc. (NFE). Click either name above to swap in a different company.
New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -259.7%, a 267.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -7.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-134.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -26.8%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
COLL vs NFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $326.2M |
| Net Profit | $17.0M | $-847.1M |
| Gross Margin | 62.5% | 35.5% |
| Operating Margin | 29.6% | -193.0% |
| Net Margin | 8.3% | -259.7% |
| Revenue YoY | 12.9% | -7.0% |
| Net Profit YoY | 35.3% | -277.4% |
| EPS (diluted) | $0.48 | $-3.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $326.2M | ||
| Q3 25 | $209.4M | $240.3M | ||
| Q2 25 | $188.0M | $228.1M | ||
| Q1 25 | $177.8M | $384.9M | ||
| Q4 24 | $181.9M | $350.7M | ||
| Q3 24 | $159.3M | $446.0M | ||
| Q2 24 | $145.3M | $291.2M | ||
| Q1 24 | $144.9M | $609.5M |
| Q4 25 | $17.0M | $-847.1M | ||
| Q3 25 | $31.5M | $-263.0M | ||
| Q2 25 | $12.0M | $-546.5M | ||
| Q1 25 | $2.4M | $-175.4M | ||
| Q4 24 | $12.5M | $-224.4M | ||
| Q3 24 | $9.3M | $9.3M | ||
| Q2 24 | $19.6M | $-88.9M | ||
| Q1 24 | $27.7M | $54.1M |
| Q4 25 | 62.5% | 35.5% | ||
| Q3 25 | 61.7% | 18.1% | ||
| Q2 25 | 57.7% | 8.4% | ||
| Q1 25 | 54.8% | 21.4% | ||
| Q4 24 | 54.0% | 17.6% | ||
| Q3 24 | 60.8% | 27.1% | ||
| Q2 24 | 62.5% | 23.8% | ||
| Q1 24 | 63.1% | 62.4% |
| Q4 25 | 29.6% | -193.0% | ||
| Q3 25 | 29.7% | -37.4% | ||
| Q2 25 | 18.7% | -170.3% | ||
| Q1 25 | 12.2% | -3.3% | ||
| Q4 24 | 20.9% | 65.0% | ||
| Q3 24 | 21.9% | 17.8% | ||
| Q2 24 | 32.7% | 12.3% | ||
| Q1 24 | 34.1% | 30.4% |
| Q4 25 | 8.3% | -259.7% | ||
| Q3 25 | 15.0% | -109.4% | ||
| Q2 25 | 6.4% | -239.6% | ||
| Q1 25 | 1.4% | -45.6% | ||
| Q4 24 | 6.9% | -64.0% | ||
| Q3 24 | 5.9% | 2.1% | ||
| Q2 24 | 13.5% | -30.5% | ||
| Q1 24 | 19.1% | 8.9% |
| Q4 25 | $0.48 | $-3.03 | ||
| Q3 25 | $0.84 | $-0.96 | ||
| Q2 25 | $0.34 | $-1.99 | ||
| Q1 25 | $0.07 | $-0.65 | ||
| Q4 24 | $0.36 | $-1.10 | ||
| Q3 24 | $0.27 | $0.03 | ||
| Q2 24 | $0.52 | $-0.42 | ||
| Q1 24 | $0.71 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $226.5M |
| Total DebtLower is stronger | — | $8.2B |
| Stockholders' EquityBook value | $301.7M | $182.6M |
| Total Assets | $1.7B | $10.6B |
| Debt / EquityLower = less leverage | — | 44.78× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $226.5M | ||
| Q3 25 | $285.9M | $145.2M | ||
| Q2 25 | $222.2M | $551.1M | ||
| Q1 25 | $197.8M | $447.9M | ||
| Q4 24 | $162.8M | $492.9M | ||
| Q3 24 | $120.0M | $90.8M | ||
| Q2 24 | $271.6M | $133.0M | ||
| Q1 24 | $318.0M | $143.5M |
| Q4 25 | — | $8.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $301.7M | $182.6M | ||
| Q3 25 | $274.8M | $1.1B | ||
| Q2 25 | $232.2M | $1.3B | ||
| Q1 25 | $234.4M | $1.8B | ||
| Q4 24 | $228.8M | $1.9B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.6B | ||
| Q1 24 | $222.2M | $1.7B |
| Q4 25 | $1.7B | $10.6B | ||
| Q3 25 | $1.6B | $12.0B | ||
| Q2 25 | $1.6B | $12.0B | ||
| Q1 25 | $1.6B | $13.1B | ||
| Q4 24 | $1.7B | $12.9B | ||
| Q3 24 | $1.6B | $12.0B | ||
| Q2 24 | $1.1B | $11.4B | ||
| Q1 24 | $1.1B | $10.9B |
| Q4 25 | — | 44.78× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.74× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-76.2M |
| Free Cash FlowOCF − Capex | $122.4M | $-134.8M |
| FCF MarginFCF / Revenue | 59.6% | -41.3% |
| Capex IntensityCapex / Revenue | 0.3% | 18.0% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-76.2M | ||
| Q3 25 | $78.4M | $-171.0M | ||
| Q2 25 | $72.4M | $-329.0M | ||
| Q1 25 | $55.4M | $-7.2M | ||
| Q4 24 | $84.6M | $445.3M | ||
| Q3 24 | $-9.0M | $-20.0M | ||
| Q2 24 | $67.4M | $113.9M | ||
| Q1 24 | $61.9M | $63.0M |
| Q4 25 | $122.4M | $-134.8M | ||
| Q3 25 | $78.3M | $-231.6M | ||
| Q2 25 | $72.4M | $-726.7M | ||
| Q1 25 | $54.6M | $-262.3M | ||
| Q4 24 | $84.1M | $-210.3M | ||
| Q3 24 | $-9.2M | $-367.0M | ||
| Q2 24 | $67.1M | $-493.2M | ||
| Q1 24 | $61.4M | $-457.9M |
| Q4 25 | 59.6% | -41.3% | ||
| Q3 25 | 37.4% | -96.4% | ||
| Q2 25 | 38.5% | -318.6% | ||
| Q1 25 | 30.7% | -68.2% | ||
| Q4 24 | 46.2% | -60.0% | ||
| Q3 24 | -5.8% | -82.3% | ||
| Q2 24 | 46.2% | -169.3% | ||
| Q1 24 | 42.3% | -75.1% |
| Q4 25 | 0.3% | 18.0% | ||
| Q3 25 | 0.1% | 25.2% | ||
| Q2 25 | 0.0% | 174.4% | ||
| Q1 25 | 0.4% | 66.3% | ||
| Q4 24 | 0.3% | 187.0% | ||
| Q3 24 | 0.2% | 77.8% | ||
| Q2 24 | 0.2% | 208.4% | ||
| Q1 24 | 0.4% | 85.5% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | -2.15× | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
